ASXC News and Press, Asensus Surgical Inc Com From 08/05/21

Asensus Surgical, Inc. (ASXC) Q2 2021 Earnings Conference Call August 5, 2021 04:30 PM ET Company Participants Mark Klausner - Westwicke, Investor Relations Anthony Fernando - President & Chief Executive Officer Shameze Rampertab - Chief Financial Officer Conference Call Participants Pres...

Asensus Surgical (NYSE:ASXC): Q2 Non-GAAP EPS of -$0.05 beats by $0.01; GAAP EPS of -$0.06 in-line. Revenue of $1.1M (+66.7% Y/Y) misses by $0.53M. The Company had cash and cash equivalents and restricted cash of approximately $158.1M as of June 30, 2021. Upcoming 2021 Milestones: For the ful...

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the second quarter 2021. ...

Asensus Surgical (ASXC) shares surge more than 25% premarket after the company received FDA 510k clearance for 5 mm diameter articulating instruments, adding to the Senhance Surgical System technology platform.Articulating instruments offer better access to difficult-to-reach a...

Instrument platform expected to expand dexterity and add capability to Senhance ® Surgical System Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Per...

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing two new board membe...

3 Biotech Penny Stocks for Your August Watchlist Biotech penny stocks are some of the hottest stocks of the past year and a half. While many investors have been focusing on popular penny stocks like AMC stock and GME stock, biotech small-caps have quietly been making big gains. Ther...

Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2021 second quarter financial and operating r...

The following slide deck was published by Asensus Surgical, Inc. in conjunction with this event. For further details see: Asensus Surgical (ASXC) Presents At Ladenburg Thalmann 2021 Virtual Healthcare Conference - Slideshow

On June 8, aspiring digital surgery company Asensus Surgical (NYSEMKT: ASXC) announced that its stock would be added to the Russell 2000 and Russell Microcap Indexes effective Monday, June 28.This announcement sent shares up 35% in June, compared with the S&P 500's 2% increase. ...